FDA approves Roche's bleeding disorder drug

Roche said on Thursday it received approval from U.S. regulators for its hemophilia A drug Hemlibra for use in nearly all patients, as the Swiss drugmaker pushes deeper into diseases beyond cancer to replace revenue from older, patent-expired drugs.